Show simple item record

dc.contributor.authorKolias, Angelosen
dc.contributor.authorEdlmann, Ellieen
dc.contributor.authorThelin, Ericen
dc.contributor.authorBulters, Diederiken
dc.contributor.authorHolton, Patricken
dc.contributor.authorSuttner, Nigelen
dc.contributor.authorOwusu-Agyemang, Kevinen
dc.contributor.authorAl-Tamimi, Yahia Zen
dc.contributor.authorGatt, Danielen
dc.contributor.authorThomson, Simonen
dc.contributor.authorAnderson, Ian Aen
dc.contributor.authorRichards, Oliveren
dc.contributor.authorWhitfield, Peteren
dc.contributor.authorGherle, Monicaen
dc.contributor.authorCaldwell, Karenen
dc.contributor.authorDavis-Wilkie, Carolen
dc.contributor.authorTarantino, Silviaen
dc.contributor.authorBarton, Garryen
dc.contributor.authorMarcus, Hani Jen
dc.contributor.authorChari, Aswinen
dc.contributor.authorBrennan, Paulen
dc.contributor.authorBelli, Antonioen
dc.contributor.authorBond, Simonen
dc.contributor.authorTurner, Caroleen
dc.contributor.authorWhitehead, Lynneen
dc.contributor.authorWilkinson, Ianen
dc.contributor.authorHutchinson, Peteren
dc.contributor.authorBritish Neurosurgical Trainee Research Collaborative (BNTRC) and Dex-CSDH Trial Collaborators,en
dc.date.accessioned2019-02-08T00:30:32Z
dc.date.available2019-02-08T00:30:32Z
dc.date.issued2018-12-04en
dc.identifier.issn1745-6215
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/288897
dc.format.mediumElectronicen
dc.languageengen
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectBritish Neurosurgical Trainee Research Collaborative (BNTRC) and Dex-CSDH Trial Collaboratorsen
dc.subjectHumansen
dc.subjectHematoma, Subdural, Chronicen
dc.subjectDexamethasoneen
dc.subjectGlucocorticoidsen
dc.subjectTreatment Outcomeen
dc.subjectDrug Administration Scheduleen
dc.subjectDouble-Blind Methoden
dc.subjectTime Factorsen
dc.subjectCost-Benefit Analysisen
dc.subjectDrug Costsen
dc.subjectMulticenter Studies as Topicen
dc.subjectRandomized Controlled Trials as Topicen
dc.subjectUnited Kingdomen
dc.titleDexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial.en
dc.typeArticle
prism.issueIdentifier1en
prism.publicationDate2018en
prism.publicationNameTrialsen
prism.startingPage670
prism.volume19en
dc.identifier.doi10.17863/CAM.36160
dcterms.dateAccepted2018-11-12en
rioxxterms.versionofrecord10.1186/s13063-018-3050-4en
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2018-12-04en
dc.contributor.orcidKolias, Angelos [0000-0003-3992-0587]
dc.contributor.orcidEdlmann, Ellie [0000-0002-7253-9115]
dc.contributor.orcidThelin, Eric [0000-0002-2338-4364]
dc.contributor.orcidBulters, Diederik [0000-0001-9884-9050]
dc.contributor.orcidChari, Aswin [0000-0003-0053-147X]
dc.contributor.orcidBelli, Antonio [0000-0002-3211-9933]
dc.contributor.orcidBond, Simon [0000-0003-2528-1040]
dc.contributor.orcidWilkinson, Ian [0000-0001-6598-9399]
dc.contributor.orcidHutchinson, Peter [0000-0002-2796-1835]
dc.identifier.eissn1745-6215
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idDepartment of Health (via National Institute for Health Research (NIHR)) (NF-SI-0515-10093)
pubs.funder-project-idBritish Heart Foundation (FS/12/33/29561)
pubs.funder-project-idBritish Heart Foundation (FS/07/001/21990)
pubs.funder-project-idBritish Heart Foundation (FS/12/8/29377)
pubs.funder-project-idNIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) (HTA/13/15/02)
pubs.funder-project-idMRC (G0601025)
pubs.funder-project-idMRC (G1002277)
pubs.funder-project-idMRC (G0600986)
pubs.funder-project-idMRC (G9439390)
pubs.funder-project-idNIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) (HTA/12/35/57)
pubs.funder-project-idTCC (NIHR-RP-R3-12-013)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International